483
Seaway Pharma Inc.FDA 483 - Seaway Pharma Inc. - June 18, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Seaway Pharma Inc. in Massena, NY, was cited for multiple significant deficiencies during an FDA inspection from May 19 to June 18, 2025. Observations included failures in quality control unit oversight, inadequate laboratory testing and record-keeping, and poor facility sanitation. The firm also lacked proper process validation and controls to ensure drug product identity, strength, purity, and quality.
Open in Dashboard
ID · 8a7c810d-9db1-43b3-8e6d-2b32a0a584a4